Research Reports
The market for femtech in Europe is dominated by the United Kingdom, which is anticipated to expand at a CAGR of 14.1% during the projected period. The rise of Femtech start-ups and government financing are factors contributing to this increase.
NEWARK, Del: The femtech market revenue will reach US$ 1.2 billion in 2023. The overall market is estimated to reach US$ 5.0 Bn by 2033, increasing at a CAGR of 15.2% from 2023 to 2033. Growth prospects are projected to stay favourable for the foreseeable future, aided by a growing demographic of working women.
Emergence of Femtech Solutions And Technology
Devices, software, and services are all included in this subsegment of the femtech market. Growing prevalence of chronic and infectious diseases in the female population base will increase the need for better diagnosis and treatment options, driving the segment’s growth.
Businesses are always putting their attention into the creation of cutting-edge, new methods for enhancing the health and wellness of women. Improvements in women’s health goods among others will help the market grow.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11761
The disparity between urban and rural areas, population inconsistency, and demographics are identified as the main femtech market limitations. Societal expectations for women’s health, particularly those concerning menstruation, fertility, sexual well-being, and birth control, are intended to restrain market expansion.
The development of the femtech sector in developing nations may be hampered by women users’ lack of knowledge about the products and applications available. A rising number of femtech businesses, including start-ups, are creating a highly competitive sector.
The Asia Pacific region is predicted to have one of the greatest femtech market shares due to the rising number of patients in countries such as India and China. In the United States, rising awareness of women’s health issues, especially menstrual and fertility health has resulted in the acceptance of Femtech solutions.
The primary players are concerned with offering services such as tailored prenatal care. These factors lead to the country’s increased adoption of Femtech services. The expanding prevalence of menstrual issues, which is driving higher market acceptance of direct-to-consumer marketing, indicates that Femtech is gaining pace.
“The advent of technological improvements in healthcare in the form of devices, applications, services, and products has increased the rate of diagnosis of reproductive disorders in terms of time management and treatments for women. This will aid growth through the upcoming decade,” says the FMI Analyst
Ask An Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-11761
Key Takeaways
- In the femtech market Diagnostics in the service segment are to grow at a CAGR of 13.2% through 2033.
- Menstrual Health is expected to accelerate at a CAGR of 12.4% in the femtech market through 2033.
- During the projection period, the U.S. market for femtech is expected to grow at a CAGR of 12.2% and reach US$ 1.4 Bn by 2033.
- Femtech sales in the United Kingdom are expected to grow at a CAGR of 14.3% over the forecasted period and hit US$ 274.6 Mn by 2033.
- By 2033, the China femtech market is set to reach US$ 438.9 Mn, registering a CAGR of 17.1%.
- Femtech sales in Japan are likely to increase by a CAGR of 18% over the forecasted period and achieve US$ 368.1 Mn by 2033.
- During the forthcoming years, the market for femtech in South Korea is assumed to expand at a CAGR of 19.9% and attain US$ 107.7 Mn by 2033.
Ask for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-11761
Competitive Landscape
Some of the market leaders in femtech include Flo Health, Inc., Apple, Inc., Clue by Biowink GmbH, Glow, Inc., Google, Inc., Natural Cycles USA Corp., Withings, and Fitbit, Inc. Market players throughout the world are being compelled to provide novel product offerings and technical solutions as a result of the increased demands brought on by the unmet healthcare needs of the female population.
To increase their commercial reach, key participants are concentrating on mergers and acquisitions and technology partnership methods.
Recent Development
- Partnership – February 2018
Clue and Fitbit worked together to improve women’s access to healthcare in February 2018. The partnership allowed the business to take advantage of market opportunities and increase the number of its current clients.
- Product Launch – May 2019
Tampax PURE, an organic, chlorine bleach, and dye tampon, was introduced in May 2019 by Tampax and Always, one of P&G’s top period care brands. The company’s product offers will be improved by this innovative product introduction, which will also improve its financial performance in the market.
Femtech by Category
By Service
- Diagnostics
- Monitoring
- Therapeutic
By Application
- General Health and Wellness
- Maternity Care
- Menstrual Health
- Pelvic and Uterine Healthcare
- Cancer and Chronic Disease
By End User
- Direct-to-consumer
- Hospitals
- Surgical Centers
- Fertility Clinics
- Diagnostics Centers
By Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
Full Report @ https://www.futuremarketinsights.com/reports/femtech-market
Table of Content
1.Executive Summary
1.1. Global Market Outlook
1.2. Global Femtech Needs Overview
1.3. Market Evolution
1.4. Analysis and Recommendations
- Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
Explore FMI’s Extensive Coverage On Healthcare Domain:
Vaginal Spetula Market Size : A gynaecological tool called a vaginal spetula is used to inspect the vagina and cervix. To retract the posterior vaginal wall, a vaginal spetula is introduced into the vagina.
Fertility and Pregnancy Rapid Test Kits Market Share : The market for fertility and pregnancy rapid test kits is anticipated to grow from an estimated valuation of US$ 1.34 billion in 2022 to US$ 1.88 billion by 2030, expanding at a CAGR of 4.3%.
Ovulation Microscope Market Demand : The global ovulation microscope market size is anticipated to reach US$ 81.2 Billion in 2032 and exhibit growth at a CAGR of 11.3% in the forecast period from 2022 to 2032.
Ovulation Test Kit Market Growth : The market for ovulation test kits generated US$ 180 million in 2021 and is anticipated to grow 8.6% year over year to reach US$ 195 million in 2022.
U.S. Digital Pregnancy Test Kits Market Opportunity : The most popular items on the market are branded test kits, which will produce almost 87% of all sales by 2031. Branded test kits have become more popular on the market as a result of their accessibility and variety of alternatives.
About Future Market Insights, Inc :
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
